Clinical trial
Comparison of Cervical Intraepithelial Neoplasia 2/3 Treatment Outcomes With a Portable LMIC-adapted Thermal Ablation Device vs. Gas-based Cryotherapy
NCT03429582 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Cervical Intraepithelial Neoplasia 2/3 Treatment Outcomes With a Portable LMIC-adapted Thermal Ablation Device vs. Gas-based Cryotherapy
- Lead sponsor
- The Cleveland Clinic
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 30, 2020
- Completion date
- July 1, 2025
- Enrollment
- 1,154 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cervical intraepithelial neoplasia